Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -12.27% vs 0.23% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 222.80% vs -125.56% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 1,112.64% vs -96.05% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -15.71% vs 18.64% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of KYORIN Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -12.27% vs 0.23% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -1.90% vs 6.37% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 222.80% vs -125.56% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -60.76% vs 137.29% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 1,112.64% vs -96.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -39.83% vs 50.71% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -15.71% vs 18.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -7.81% vs 255.56% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






